SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,944,000 | -43.4% | 52,928 | +29.4% | 0.00% | -50.0% |
| Q4 2020 | $6,973,000 | +57.6% | 40,901 | +29.8% | 0.01% | +20.0% |
| Q3 2020 | $4,424,000 | -85.9% | 31,500 | -83.8% | 0.01% | -86.5% |
| Q2 2020 | $31,266,000 | +80.7% | 194,995 | +10.3% | 0.04% | +23.3% |
| Q1 2020 | $17,301,000 | -22.5% | 176,864 | +2.3% | 0.03% | +15.4% |
| Q4 2019 | $22,314,000 | +73.1% | 172,929 | +1.1% | 0.03% | +36.8% |
| Q3 2019 | $12,888,000 | -56.5% | 171,113 | -12.2% | 0.02% | -20.8% |
| Q2 2019 | $29,607,000 | +60.7% | 194,845 | +26.0% | 0.02% | -7.7% |
| Q1 2019 | $18,428,000 | +45.0% | 154,611 | +32.8% | 0.03% | +116.7% |
| Q4 2018 | $12,705,000 | -32.6% | 116,417 | -0.3% | 0.01% | -52.0% |
| Q3 2018 | $18,850,000 | +37.9% | 116,712 | +12.9% | 0.02% | +25.0% |
| Q2 2018 | $13,670,000 | +271.6% | 103,418 | +108.2% | 0.02% | +233.3% |
| Q1 2018 | $3,679,000 | – | 49,662 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
| EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
| Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
| Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
| Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
| Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
| Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
| ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
| Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |